Lene Martin1,2 1School of Health, Care and Social Welfare, Mälardalen University, Eskilstuna, Sweden; 2School of Health Sciences, City, University of London, London, UK Purpose: The purpose of this study was to investigate the extent to which ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, changes in diet, or smoking cessation to patients who are at risk of or with signs of age-related macular degeneration (AMD). In addition, this study also examined how these practitioners rate the strength of evidence for nutritional supplements in AMD management and which sources of information they consult to determine supplement recommendations for the prevention or treatment of AMD. Methods: This study im...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
: Eye care professionals should have access to high quality clinical practice guidelines that ideall...
Age-related macular degeneration (AMD) is a progressive disorder primarily affecting the macula, the...
Age-related macular degeneration (AMD) is the leading cause for visual impairment and blindness regi...
BACKGROUND: In the absence of a cure, there has been considerable interest in attempts to prevent or...
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in ...
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. Despi...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Background: Age-related macular degeneration (AMD) is responsible for half of registered visual impa...
© The Author(s) 2017. Age-related macular disease (AMD) is a multifactorial degenerative condition a...
Research has shown that individuals affected by age-related macular degeneration (AMD) do not always...
AIM: To establish the frequency, associations and risk factors for age-related macular degeneration(...
Age-Related Eye Disease Study supplement; age-related macular degeneration; awareness; compliance; p...
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In ...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
: Eye care professionals should have access to high quality clinical practice guidelines that ideall...
Age-related macular degeneration (AMD) is a progressive disorder primarily affecting the macula, the...
Age-related macular degeneration (AMD) is the leading cause for visual impairment and blindness regi...
BACKGROUND: In the absence of a cure, there has been considerable interest in attempts to prevent or...
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in ...
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. Despi...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Background: Age-related macular degeneration (AMD) is responsible for half of registered visual impa...
© The Author(s) 2017. Age-related macular disease (AMD) is a multifactorial degenerative condition a...
Research has shown that individuals affected by age-related macular degeneration (AMD) do not always...
AIM: To establish the frequency, associations and risk factors for age-related macular degeneration(...
Age-Related Eye Disease Study supplement; age-related macular degeneration; awareness; compliance; p...
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In ...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
: Eye care professionals should have access to high quality clinical practice guidelines that ideall...
Age-related macular degeneration (AMD) is a progressive disorder primarily affecting the macula, the...